About Mounjaro
*In studies with or without diabetes medications, 75% to 90% of people taking Mounjaro reached an A1C of less than 7%, with an average starting A1C of 7.9% to 8.6% across the 5-mg, 10-mg, and 15-mg doses.
†Study results were measured at 40 and 52 weeks.
Select Safety Information
Kidney problems (kidney failure). In people who have kidney problems, diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems to get worse. It is important for you to drink fluids to help reduce your chance of dehydration.
Mounjaro is not a weight loss drug.
‡Individual results may vary. In studies with or without other diabetes medications, weight loss in adults ranged from 12 lb (5 mg) to 25 lb (15 mg).
Select Safety Information
Severe stomach problems. Stomach problems, sometimes severe, have been reported with Mounjaro. Tell your healthcare provider if you have stomach problems that are severe or will not go away.
See how Mounjaro compares
In clinical studies, Mounjaro was compared to some other medicines for type 2 diabetes.
Mounjaro A1C results ||| h3
Mounjaro weight results ||| h3
Select Safety Information
Changes in vision. Tell your healthcare provider if you have changes in vision during treatment with Mounjaro.
Once-weekly Mounjaro is here to help you lower your A1C*
*Along with diet and exercise.
Talk to your doctor about Mounjaro at your next visit ||| h4

Mounjaro Savings
We want to help. You may pay as little as $25 for a 1-month or 3-month prescription with the Mounjaro Savings Card. * † ||| h3
*For eligible commercially insured patients with Mounjaro coverage. Governmental beneficiaries excluded, terms and conditions apply.
†One month is defined as 28 days and 4 pens. Three months is defined as 84 days and up to 12 pens.